SAN DIEGO & LOS ANGELES--(BUSINESS WIRE)--Biocom, the association representing the life science industry of California, today announced that Dina Lozofsky, the organization’s executive director for its Los Angeles office, was appointed to serve on the governing board of Bioscience Los Angeles County (https://www.biolac.org/).
BioLA was founded in 2018 to ensure Los Angeles has a collaborative, well-coalesced ecosystem that encompasses all aspects of the Southern California life sciences cluster. The organization will focus on harmonizing the efforts of the many regional stakeholders working to advance Los Angeles’ life science entrepreneurial capacity and pace of innovation, including academic institutions, research hospitals, investors, startups, mature companies, trade associations, and public and quasi-public agencies.
The BioLA initiative was launched by Los Angeles County in recognition that this industry is important to economic development in the LA area and that support of the industry is served by a public-private partnership. In addition to County of Los Angeles, BioLA founding sponsors include Amgen, PhRMA, Richard Lundquist, Richard Merkin and others to be announced soon, who will all have representation on the governing board.
“The County of Los Angeles was the fundamental guiding force in the creation of BioLA, and it’s gratifying to see their deep commitment to our industry,” said Ms. Lozofsky. “With their support and that of the other founding sponsors, we are adding to the growing momentum that the LA life sciences industry has enjoyed for the last three years. Biocom and I are pleased to participate in the efforts of this organization, which will amplify the work Biocom is doing on behalf of our Los Angeles area members.”
Biocom opened its office in Los Angeles in 2016 with the goal of accelerating the growth of a thriving, dynamic life sciences community, leveraging the many building blocks that were already in place: robust research institutions and hospitals, mature pharmaceutical and medical device companies, as well as a highly skilled pool of life science graduates.
“We established our Los Angeles office to help advance the growth of the industry here, collaborated with a range of organizations, including member organizations and other partners, and our efforts have borne fruit,” said Joe Panetta, CEO of Biocom. “New venture capital funds have been established specifically to support life sciences in LA, and many incubators have established a footprint in the county, both of which will help Los Angeles’ talented workforce and homegrown technologies stay in the area.”
About Biocom
Biocom is the largest, most experienced leader and advocate for California’s life science sector. We work on behalf of more than 1,100 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs, and create robust value-driven purchasing programs.
Founded in 1995 in San Diego, Biocom provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to our San Diego headquarters, Biocom operates core offices in Los Angeles and the San Francisco Bay Area, satellite offices in Washington, D.C. and Tokyo, and has a continuous staff presence in Sacramento. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers.
For more information on Biocom, please visit our website at www.biocom.org. Connect with us on LinkedIn, Facebook, and Twitter (@BIOCOMCA).
